After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Processa Pharmaceuticals Inc is $3.27M. A total of 49851.0 shares were traded on the day, compared to an average of 362.13K shares.
In the most recent transaction, Young David bought 21,000 shares of PCSA for 2.45 per share on Feb 07 ’24. After the transaction, the Pres. Research & Development now owns 79,387 company shares. In a previous transaction on Feb 06 ’24, Young David bought 20,000 shares at 2.53 per share. PCSA shares that Pres. Research & Development owns now total 58,387.
Among the insiders who bought shares, Lin Patrick acquired of 2,500 shares on Jan 31 ’24 at a per-share price of $2.37. This resulted in the Chief Business – Strategy Off holding 25,978 shares of PCSA after the transaction. In another insider transaction, Lin Patrick bought 1,500 shares at $2.40 per share on Feb 01 ’24. Company shares held by the Chief Business – Strategy Off now total 27,478.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PCSA has a high of $7.40 and a low of $0.81.
As of this writing, PCSA has an earnings estimate of -$0.92 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.92 per share and a lower estimate of -$0.92.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PCSA’s latest balance sheet shows that the firm has $16.50M in Cash & Short Term Investments as of fiscal 2021. There were $78.46k in debt and $971.02k in liabilities at the time. Its Book Value Per Share was $1.14, while its Total Shareholder’s Equity was $25.49M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCSA is Buy with a score of 4.33.
